Neuroimaging in Alzheimer disease: An evidence-based review

被引：140

作者：

Kantarci, K ^{[1
]}

Jack, CR ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Dept Radiol, Rochester, MN 55905 USA

来源：

NEUROIMAGING CLINICS OF NORTH AMERICA | 2003年 / 13卷 / 02期

关键词：

D O I：

10.1016/S1052-5149(03)00025-X

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Alzheimer disease (AD) is the most prevalent of dementia syndromes. The number of elderly individuals affected with the disease is expected to grow with increasing life expectancy. There is no definite biomarker available for the diagnosis of AD; clinical criteria are currently used. Neuroimaging can identify potentially treatable causes of dementia, and it is also sensitive to the early structural and functional changes in the brains of patients with AD. This article reviews the evidence on the usefulness of neuroimaging in clinical evaluation of AD and as a surrogate marker for early detection and disease progression.

引用

页码：197 / +

页数：60

共 97 条

[1] Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease [J].

Adalsteinsson, E ;

Sullivan, EV ;

Kleinhans, N ;

Spielman, DM ;

Pfefferbaum, A .

LANCET, 2000, 355 (9216) :1696-1697

[2]

[Anonymous], 1997, Neurobiol Aging, V18, pS1

[3]

[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th

[4] NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE [J].

ARRIAGADA, PV ;

GROWDON, JH ;

HEDLEYWHYTE, ET ;

HYMAN, BT .

NEUROLOGY, 1992, 42 (03) :631-639

[5] CROSS-NATIONAL INTERRATER AGREEMENT ON THE CLINICAL DIAGNOSTIC-CRITERIA FOR DEMENTIA [J].

BALDERESCHI, M ;

AMATO, MP ;

NENCINI, P ;

PRACUCCI, G ;

LIPPI, A ;

AMADUCCI, L ;

GAUTHIER, S ;

BEATTY, L ;

QUIROGA, P ;

KLASSEN, G ;

GALEA, A ;

MUSCAT, P ;

OSUNTOKUN, B ;

OGUNNIYI, A ;

PORTERASANCHEZ, A ;

BERMEJO, F ;

HENDRIE, H ;

BURDINE, V ;

BRASHEAR, A ;

FARLOW, M ;

MAGGI, S ;

KATZMAN, R .

NEUROLOGY, 1994, 44 (02) :239-242

[6] Apolipoprotein E ε4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias [J].

Barber, R ;

Gholkar, A ;

Scheltens, P ;

Ballard, C ;

McKeith, IG ;

Morris, CM ;

O'Brien, JT .

ARCHIVES OF NEUROLOGY, 1999, 56 (08) :961-965

[7] THE PREVALENCE OF DEMENTIA IS CHANGING OVER TIME IN ROCHESTER, MINNESOTA [J].

BEARD, CM ;

KOKMEN, E ;

OBRIEN, PC ;

KURLAND, LT .

NEUROLOGY, 1995, 45 (01) :75-79

[8] RELIABILITY AND VALIDITY OF NINCDS-ADRDA CRITERIA FOR ALZHEIMERS-DISEASE - THE NATIONAL-INSTITUTE-OF-MENTAL-HEALTH GENETIC INITIATIVE [J].

BLACKER, D ;

ALBERT, MS ;

BASSETT, SS ;

GO, RCP ;

HARRELL, LE ;

FOLSTEIN, MF .

ARCHIVES OF NEUROLOGY, 1994, 51 (12) :1198-1204

[9]

Bobinski M, 2000, NEUROSCIENCE, V95, P721

[10] Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients [J].

Bonte, FJ ;

Weiner, MF ;

Bigio, EH ;

White, CL .

RADIOLOGY, 1997, 202 (03) :793-797

← 1 2 3 4 5 6 7 8 9 10 →